Bicycle Therapeutics plc Operating Lease, Weighted Average Discount Rate, Percent
Bicycle Therapeutics plc (BCYC) had Operating Lease, Weighted Average Discount Rate, Percent of 6.30% as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-07-30
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 6.30%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 6.30%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.40%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 7.50%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2026-06-30 | 6.30% 10-Q · filed 2026-07-30 | |
| 2026-03-31 | 6.30% 10-Q · filed 2026-04-30 | |
| 2025-12-31 | 6.40% 10-K · filed 2026-03-17 | |
| 2025-09-30 | 7.50% 10-Q · filed 2025-10-30 | |
| 2025-06-30 | 7.70% 10-Q · filed 2026-07-30 | |
| 2025-03-31 | 7.70% 10-Q · filed 2026-04-30 | |
| 2024-12-31 | 7.80% 10-K · filed 2026-03-17 | |
| 2024-09-30 | 7.80% 10-Q · filed 2025-10-30 | |
| 2024-06-30 | 7.90% 10-Q · filed 2025-08-08 | |
| 2024-03-31 | 7.90% 10-Q · filed 2025-05-01 | |
| 2023-12-31 | 7.90% 10-K · filed 2025-02-25 | |
| 2023-09-30 | 7.90% 10-Q · filed 2024-10-31 | 7.94% 10-Q · filed 2023-11-02 |
| 2023-06-30 | 7.60% 10-Q · filed 2024-08-06 | 7.61% 10-Q · filed 2023-08-03 |
| 2023-03-31 | 7.60% 10-Q · filed 2024-05-02 | 7.62% 10-Q · filed 2023-05-04 |
| 2022-12-31 | 7.00% 10-K · filed 2024-02-20 | |
| 2022-09-30 | 7.03% 10-Q · filed 2023-11-02 | |
| 2022-06-30 | 7.04% 10-Q · filed 2023-08-03 | |
| 2022-03-31 | 7.04% 10-Q · filed 2023-05-04 | |
| 2021-12-31 | 7.10% 10-K · filed 2023-02-28 | |
| 2021-09-30 | 7.89% 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 7.92% 10-Q · filed 2022-08-04 | |
| 2021-03-31 | 7.93% 10-Q · filed 2022-05-05 | |
| 2020-12-31 | 8.60% 10-K · filed 2022-03-01 | 8.56% 10-K · filed 2021-03-11 |
| 2020-09-30 | 8.61% 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 8.59% 10-Q · filed 2021-08-05 | |
| 2020-03-31 | 8.56% 10-Q · filed 2021-05-06 | |
| 2019-12-31 | 8.50% 10-K · filed 2022-03-01 | 8.52% 10-K · filed 2020-03-10 |
| 2019-09-30 | 8.50% 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 8.50% 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |